(S1 (S (NP (NNP Genentech) (NNP Inc.)) (VP (VBD said) (SBAR (S (NP (JJ third-quarter) (NN profit)) (VP (ADVP (RBR more) (IN than)) (VBD doubled) (PP (TO to) (NP (NP (QP ($ $) (CD 11.4) (CD million))) (, ,) (CC or) (NP (NP (CD 13) (NNS cents)) (NP (DT a) (NN share))) (, ,))) (PP (IN from) (NP (NP (DT a) (VBN depressed) (CD 1988) (NN third-quarter) (NN performance)) (PP (IN of) (NP (NP (QP ($ $) (CD 5.3) (CD million))) (, ,) (CC or) (NP (NP (CD six) (NNS cents)) (NP (DT a) (NN share))))))))))) (. .)))

(S1 (S (NP (NN Revenue)) (VP (VBD rose) (NP (CD 23) (NN %)) (PP (TO to) (NP (QP ($ $) (CD 100) (CD million)))) (PP (IN from) (NP (QP ($ $) (CD 81.6) (CD million))))) (. .)))

(S1 (S (NP (JJ Net) (NN product) (NNS sales)) (VP (VBD accounted) (PP (IN for) (NP (NP (QP ($ $) (CD 76) (CD million))) (, ,) (ADVP (RB up) (PP (IN from) (NP (QP ($ $) (CD 57.5) (CD million))) (ADVP (NP (DT a) (NN year)) (RBR earlier))))))) (. .)))

(S1 (S (NP (NP (NNS Sales)) (PP (IN of) (NP (DT the) (NN heart) (NN drug) (NNP TPA)))) (VP (VBD were) (NP (NP (QP ($ $) (CD 43.6) (CD million))) (, ,) (ADJP (ADJP (JJR better)) (PP (IN than) (NP (NP (NP (JJ last) (NN year) (POS 's)) (JJ depressed) (JJ third) (NN period)) (SBAR (WHADVP (WRB when)) (S (NP (DT the) (NN company)) (VP (VBD sold) (NP (NP (QP (RB just) ($ $) (CD 29.1) (CD million))) (PP (IN of) (NP (DT the) (NN drug)))))))))))) (. .)))

(S1 (S (CC But) (NP (NNP TPA) (NNS sales)) (VP (VBD fell) (PP (IN below) (NP (NP (NNS levels)) (PP (IN for) (NP (NP (DT this) (NN year) (POS 's)) (ADJP (JJ first) (CC and) (JJ second)) (NN quarter))))) (NP (NP (NNS sales)) (PP (IN of) (NP (QP ($ $) (CD 48) (CD million))))) (, ,) (S (VP (VBG cooling) (NP (NNS investors))))) (. .)))

(S1 (S (NP (NNP Genentech) (NN stock)) (VP (VBD fell) (NP (CD 12.5) (NNS cents)) (PP (IN in) (NP (NP (NN trading)) (NP (NN yesterday)) (PP (IN on) (NP (DT the) (NNP New) (NNP York) (NNP Stock) (NNP Exchange))))) (PP (TO to) (NP ($ $) (CD 20.125)))) (. .)))

(S1 (S (PP (IN In) (NP (DT the) (CD nine) (NNS months))) (, ,) (NP (JJ net) (NN income)) (VP (VBD slid) (NP (CD 21) (NN %)) (PP (TO to) (NP (NP (QP ($ $) (CD 28.4) (CD million))) (, ,) (CC or) (NP (NP (CD 33) (NNS cents)) (NP (DT a) (NN share))) (, ,))) (PP (IN from) (NP (NP (QP ($ $) (CD 36) (CD million))) (, ,) (CC or) (NP (NP (CD 42) (NNS cents)) (NP (DT a) (NN share)))))) (. .)))

(S1 (S (NP (NNS Revenues)) (VP (VBD climbed) (NP (CD 18) (NN %)) (PP (TO to) (NP (QP ($ $) (CD 289) (CD million)))) (PP (IN from) (NP (QP ($ $) (CD 245.3) (CD million))))) (. .)))

(S1 (SINV (`` `) (S (`` `) (NP (PRP We)) (VP (VBP continue) (S (VP (TO to) (VP (VB be) (PP (IN on) (NP (NN target))) (PP (IN for) (NP (NN ..))))))) (. .)) (VP (VBG increasing) (NP (NNP TPA) (NNS sales) (NP (NP (QP (CD 20) (NN %) (TO to) (CD 25) (NN %))) (NP (DT this) (NN year))))) (, ,) ('' ') ('' ') (VP (VBD said)) (NP (NP (NP (NN founder)) (CC and) (NP (JJ Chief) (JJ Executive) (NN Officer))) (NP (NNP Robert) (NNP Swanson))) (. .)))

(S1 (S (CC But) (NP (DT some) (NNS analysts)) (VP (VBP remain) (ADJP (JJ sour)) (PP (IN on) (NP (DT the) (NN company)))) (. .)))

(S1 (FRAG (`` `) (`` `) (S (NP (NNP TPA) (NNS sales)) (VP (VBP are) (PP (PP (IN down) (NP (NN quarter))) (PP (TO to) (NP (NN quarter)))))) (. .)))

(S1 (S (S (NP (NNS Expenses)) (VP (VBP are) (ADJP (JJ flat)))) (CC and) (S (NP (DT that)) (VP (VBZ 's) (NP (DT a) (JJ good) (NN sign)))) (. .)))

(S1 (S (NP (EX There)) (VP (VBZ 's) (NP (NP (NN contract) (NN revenue)) (PP (IN from) (NP (-LRB- -LCB-) (JJ limited) (NN research) (CC and) (NN development) (-RRB- -RCB-) (NNS partnerships))))) (. .)))

(S1 (SINV (S (CC But) (NP (PRP I)) (ADVP (RB still)) (VP (VBP think) (SBAR (S (NP (DT the) (NNS fundamentals)) (VP (VBP are) (ADJP (JJ poor))))))) (, ,) ('' ') ('' ') (VP (VBD said)) (NP (NP (NNP Denise) (NNP Gilbert)) (, ,) (NP (NP (DT an) (NN analyst)) (PP (IN with) (NP (NP (NNP Montgomery) (NNP Securities)) (PP (IN in) (NP (NNP San) (NNP Francisco))))))) (. .)))

(S1 (S (NP (NNP Genentech)) (VP (VBZ faces) (NP (NP (NN competition)) (PP (IN in) (NP (DT the) (JJ cardiac-drug) (NN market))) (PP (IN from) (NP (NP (NP (NP (NNP SmithKline) (NNP Beecham)) (NNP PLC) (POS 's)) (NN heart) (NN drug)) (NP (NNP Eminase)))) (, ,) (VP (VBN expected) (S (VP (TO to) (VP (VB receive) (NP (NN market) (NN approval)) (ADVP (RB shortly)))))))) (. .)))

(S1 (S (S (CC And) (NP (NNP Genentech)) (VP (VBZ is) (RB n't) (ADJP (JJ likely) (S (VP (TO to) (VP (VB have) (NP (NP (DT any) (JJ new) (NNS products)) (ADJP (JJ ready) (PP (IN for) (NP (NN market))))) (PP (IN until) (NP (QP (IN at) (JJS least) (CD 1992)))))))))) (, ,) (NP (NNP Ms.) (NNP Gilbert)) (VP (VBD added)) (. .)))

(S1 (S (`` `) (S (`` `) (S (NP (NP (DT The) (NN company) (POS 's)) (NN stock)) (VP (VBZ is) (VP (VBG trading) (PP (IN at) (NP (NP (QP (CD 40) (NNS times)) (JJ next) (NN year) (POS 's)) (NNS numbers)))))) (, ,) (CC and) (S (NP (DT that)) (VP (VBZ 's) (NP (RB too) (JJ much)))) (, ,) ('' ')) ('' ') (NP (PRP she)) (VP (VBD said)) (. .)))

(S1 (S (S (PP (IN On) (NP (DT the) (JJ plus) (NN side))) (, ,) (NP (NNP Genentech)) (VP (VBZ is) (VP (VBG benefiting) (PP (IN from) (NP (NP (DT a) (JJR lower) (NN tax) (NN rate)) (ADJP (JJ due) (PP (TO to) (NP (PRP$ its) (NN research) (NNS outlays)))))) (, ,) (S (VP (VBG giving) (NP (DT a) (NN boost)) (PP (TO to) (NP (NNS earnings)))))))) (, ,) (NP (PRP she)) (VP (VBD said)) (. .)))

